DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.compose your message
message sent
email sent successfully
Trusted Resources: News & Events
Latest announcements and gatherings
Inexpensive sickle cell diagnostic tool shows perfect accuracy in Uganda
An inexpensive, easy-to-use diagnostic tool for sickle cell disease showed 100% accuracy among a large cohort of children from Uganda, according to findings presented during the late-breaking abstract session of ASH Annual Meeting and Exposition.
The test — HemoTypeSC (Silver Lake Research Corporation) — only requires a drop of blood and produces results in about 10 minutes.
Diagnosis, prophylaxis, counseling and treatment have dramatically reduced sickle cell disease incidence and mortality in the developing world, but screening for the disease has not been widely implemented in those regions, particularly in sub-Saharan Africa, according to Erik Serrao, PhD, director of business and product development at Silver Lake Research Corp.
“Although this disease is acknowledged as a public health problem by the U.N. and WHO, African governments and ministries of health still largely neglect this disease,” he said during a press conference. “Individuals with this disease are commonly identified only after they die or when they present at the hospital with life-threatening symptoms.”
Related Content
-
education & researchPoint-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a...Sickle cell disease (SCD) is a common, l...
-
education & researchA Genome-Wide Association Study Identifies Blood Disorder–Related Variants Influencing Hemoglobin A1c With Implica...OBJECTIVE We aimed to identify hemoglobi...
-
news & eventsResearchers Develop Test for SCA to be Used in Low-Resource SettingsResearchers have developed an accurate, ...
-
news & eventsQuest Diagnostics Launches Genetic Test to Assess Risk for Sickle Cell Anemia, Other Inherited DisordersCouples who wish to know the risk of pas...
-
news & eventsNon-Invasive Prenatal Screening Test for Sickle Cell Appears Possible, Study ReportsA non-invasive prenatal test to diagnose...
-
news & eventsSickle cell trait may confound blood sugar readings among African-AmericansA new study in JAMA provides evidence th...
-
news & eventsGhana Launches Partnership With Novartis to Improve Diagnosis and Treatment of People With Sickle Cell DiseaseThe Government of Ghana announced a new ...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.